Protocol for a systematic review and meta-analysis of experimental models of amyotrophic lateral sclerosis

Jenna Gregory, F. M. Waldron, T. Soane, L. Fulton, D. Leighton, Jeremy Chataway, S. Pal, S. Chandran, Malcolm R. Macleod

Research output: Contribution to journalArticlepeer-review

Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease with no cure and limited treatment options. There is therefore an urgent need for effective therapeutic interventions in this disease. This protocol outlines the strategy for a systematic review and meta-analysis to identify, from in vivo animal and human induced pluripotent stem cell (hiPSC) studies, potential therapeutic interventions for ALS. Our aim is to perform a comprehensive review of the ALS literature to compile a list of (1) candidate interventions and (2) target pathways that may be of therapeutic benefit in patients with ALS.
Original languageEnglish
Pages (from-to)17-19
JournalEvidence-based Preclinical Medicine
Volume3
Issue number2
DOIs
Publication statusPublished - Dec 2016

Fingerprint

Dive into the research topics of 'Protocol for a systematic review and meta-analysis of experimental models of amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Cite this